| Literature DB >> 17394632 |
Eduardo De Stefani1, Paolo Boffetta, Hugo Deneo-Pellegrini, Pelayo Correa, Alvaro L Ronco, Paul Brennan, Gilles Ferro, Giselle Acosta, María Mendilaharsu.
Abstract
BACKGROUND: Bladder cancer is the fourth most frequent malignancy among Uruguayan men. A previous study from Uruguay suggested a high risk of bladder cancer associated with maté drinking. We conducted an additional case-control study in order to further explore the role of non-alcoholic beverages in bladder carcinogenesis.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17394632 PMCID: PMC1857703 DOI: 10.1186/1471-2407-7-57
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Distribution of controls and cases by sociodemographic variables and selected risk factors
| Age (years) | 30–39 | 2 | 0.8 | 4 | 0.8 | NA | |
| 40–49 | 14 | 5.5 | 28 | 5.6 | |||
| 50–59 | 37 | 14.5 | 74 | 14.8 | |||
| 60–69 | 91 | 35.7 | 182 | 36.3 | |||
| 70–79 | 86 | 33.7 | 175 | 34.9 | |||
| 80–89 | 25 | 9.8 | 38 | 7.6 | |||
| Sex | Males | 225 | 88.2 | 441 | 88.0 | NA | |
| Females | 30 | 11.8 | 60 | 12.0 | |||
| Residence | Montevideo | 116 | 45.5 | 254 | 50.7 | NA | |
| Other counties | 139 | 54.5 | 247 | 49.3 | |||
| Urban/rural status | Urban | 192 | 75.3 | 416 | 83.0 | 1.00 | |
| Rural | 63 | 24.7 | 85 | 17.0 | 1.31 | 0.80–2.14 | |
| Education (years) | 0–2 | 57 | 22.3 | 140 | 27.9 | 1.00 | |
| 3–5 | 106 | 41.6 | 175 | 34.9 | 1.42 | 0.93–2.17 | |
| 6+ | 92 | 36.1 | 186 | 37.2 | 1.24 | 0.79–1.95 | |
| Income (US dollars per month) | <=142 | 93 | 36.5 | 225 | 44.9 | 1.00 | |
| 143+ | 113 | 44.3 | 194 | 38.7 | 1.51 | 1.05–2.17 | |
| Missing | 49 | 19.2 | 82 | 16.4 | 1.50 | 0.94–2.40 | |
| Family history of bladder cancer | No | 244 | 95.7 | 495 | 98.8 | 1.00 | |
| Yes | 11 | 4.3 | 6 | 1.2 | 4.97 | 1.73–14.27 | |
| Body Mass Index | <=22.8 | 59 | 23.1 | 127 | 25.3 | 1.00 | |
| 22.9–25.1 | 65 | 25.5 | 126 | 25.1 | 1.13 | 0.72–1.79 | |
| 25.2–27.1 | 53 | 20.8 | 120 | 23.9 | 0.92 | 0.57–1.49 | |
| 27.2+ | 78 | 30.6 | 128 | 25.7 | 1.33 | 0.84–2.10 | |
| Occupation | Low risk | 175 | 68.6 | 385 | 76.9 | 1.00 | |
| High risk | 80 | 31.4 | 116 | 23.1 | 1.41 | 0.92–2.15 | |
| Years of smoking | Never smokers | 48 | 18.8 | 136 | 27.1 | 1.0 | Reference |
| 1–29 | 32 | 12.5 | 60 | 12.0 | 1.55 | 0.85–2.82 | |
| 30–39 | 31 | 12.2 | 70 | 14.0 | 1.34 | 0.73–2.46 | |
| 40–49 | 54 | 21.2 | 109 | 21.8 | 1.61 | 0.94–2.74 | |
| 50+ | 90 | 35.3 | 126 | 25.1 | 2.39 | 1.46–3.90 | |
| N patients | 255 | 100.0 | 501 | 100.0 | |||
NA, not applicable (matching variable)
OR, odds ratio adjusted for age, sex, residence, urban/rural status, education, family history of bladder cancer among first-degree relatives, body mass index, occupation, smoking status, years since quit, number of cigarettes smoked per day, maté drinking, coffee drinking, tea drinking, soft drinks and milk intake
CI, confidence interval
Odds ratios of bladder cancer for maté drinking
| Never drinkers | 18/71 | 1.0 | ||
| Former drinkers | 13/17 | 3.1 | 1.2–8.1 | |
| Current drinkers | 224/413 | 2.2 | 1.2–3.9 | |
| Ever drinkers | 237/430 | 2.2 | 1.2–3.9 | |
| Amount of drinking | Never drinkers | 18/71 | 1.0 | |
| (liters/day) | 0.1–0.9 | 31/89 | 1.3 | 0.6–2.7 |
| 1.0–1.9 | 125/248 | 2.1 | 1.2–3.9 | |
| 2.0+ | 81/93 | 3.7 | 1.9–7.1 | |
| p-value for trend | <0.01 | |||
| Duration of drinking | Never drinkers | 18/71 | 1.0 | |
| (years) | 1–49 | 84/180 | 1.7 | 0.9–3.3 |
| 50–59 | 85/155 | 2.4 | 1.3–4.5 | |
| 60+ | 68/95 | 3.0 | 1.5–6.0 | |
| p-value for trend | <0.01 | |||
| Cumulative consumption | Never drinkers | 18/71 | 1.0 | |
| (liters/day × years) | 1–47 | 66/156 | 1.7 | 0.9–3.3 |
| 48–69 | 77/149 | 2.1 | 1.1–3.9 | |
| 70+ | 94/127 | 3.2 | 1.7–6.0 | |
| p-value for trend | <0.01 | |||
| Temperature | Never drinkers | 18/71 | 1.0 | |
| Warm | 11/20 | 2.1 | 0.8–5.4 | |
| Hot | 191/383 | 2.1 | 1.2–3.7 | |
| Very hot | 35/27 | 4.9 | 2.2–11 |
OR, odds ratio adjusted for age, sex, residence, urban/rural status, education, family history of bladder cancer among first-degree relatives, body mass index, occupation, smoking status, years since quitting, number of cigarettes smoked per day, coffee drinking, tea drinking, soft drink intake, and milk intake
CI, confidence interval.
Odds ratios of bladder cancer for coffee, tea and soft drinks consumption
| Drinking status | Never drinkers | 135/332 | 1.0 | |
| Former drinkers | 9/13 | 1.4 | 0.6–3.6 | |
| Current drinkers | 111/156 | 1.7 | 1.2–2.3 | |
| Ever drinkers | 120/169 | 1.6 | 1.2–2.3 | |
| Amount (pure coffee) | Never drinkers | 135/332 | 1.0 | |
| (cups/week) | 1–6 | 22/28 | 1.6 | 0.8–3.1 |
| 7+ | 15/21 | 2.0 | 0.9–4.4 | |
| p-value for trend | 0.03 | |||
| Amount (coffee with milk) | Never drinkers | 135/332 | 1.0 | |
| (cups/week) | 1–6 | 70/112 | 1.5 | 1.0–2.2 |
| 7+ | 24/24 | 1.9 | 1.0–3.7 | |
| p-value for trend | 0.01 | |||
| Amount (total coffee) | Never drinkers | 135/332 | 1.0 | |
| (cups/week) | 1–6 | 84/133 | 1.5 | 1.1–2.2 |
| 7+ | 36/36 | 2.1 | 1.2–3.6 | |
| p-value for trend | <0.01 | |||
| Drinking status | Never drinkers | 180/419 | 1.0 | |
| Former drinkers | 1/2 | 1.5 | 0.1–19 | |
| Current drinkers | 74/80 | 2.3 | 1.6–3.4 | |
| Ever drinkers | 75/82 | 2.3 | 1.5–3.4 | |
| Amount (pure tea) | Never drinkers | 180/419 | 1.0 | |
| (cups/week) | 1–6 | 21/11 | 4.4 | 2.0–10 |
| 7+ | 20/32 | 1.5 | 0.8–2.8 | |
| p-value for trend | 0.02 | |||
| Amount (tea with milk) | Never drinkers | 180/419 | 1.0 | |
| (cups/week) | 1–6 | 28/40 | 1.7 | 1.0–3.0 |
| 7+ | 10/5 | 6.5 | 2.0–21 | |
| p-value for trend | <0.01 | |||
| Amount (total tea) | Never drinkers | 180/419 | 1.0 | |
| (cups/week) | 1–6 | 59/72 | 2.1 | 1.4–3.1 |
| 7+ | 16/10 | 4.1 | 1.7–9.9 | |
| p-value for trend | <0.01 | |||
| Amount | Never drinkers | 138/289 | 1.0 | |
| (bottles/years) | 1–104 | 65/121 | 1.1 | 0.7–1.6 |
| 105+ | 52/91 | 1.1 | 0.7–1.7 | |
| p-value for trend | 0.62 | |||
OR, odds ratio adjusted for age, sex, residence, urban/rural status, education, family history of bladder cancer among first-degree relatives, body mass index, occupation, smoking status, years since quitting, number of cigarettes smoked per day, maté drinking, soft drink intake, milk intake, and, when appropriate, coffee drinking and tea drinking
CI, confidence interval.
Odds ratios of bladder cancer for drinking of maté, coffee, tea, by smoking status
| Never drinkers | 10/30 | 1.0 | 8/41 | 1.0 | ||
| 1–47 | 12/48 | 0.95 | 0.32–2.86 | 54/108 | 2.51 | 1.06–5.95 |
| 48–69 | 16/38 | 1.35 | 0.46–3.95 | 61/109 | 2.97 | 1.25–7.03 |
| 70+ | 10/20 | 2.31 | 0.65–8.23 | 84/107 | 4.30 | 1.82–10.1 |
| p-value for trend | 0.2 | <0.01 | ||||
| Never drinkers | 26/91 | 1.0 | 109/241 | 1.0 | ||
| 1–6 | 17/36 | 2.22 | 0.97–5.12 | 67/97 | 1.33 | 0.88–2.00 |
| 7+ | 5/9 | 2.02 | 0.54–7.54 | 31/27 | 2.04 | 1.12–3.72 |
| p-value for trend | 0.08 | 0.01 | ||||
| Never drinkers | 34/111 | 1.0 | 146/308 | 1.0 | ||
| 1–6 | 11/20 | 2.22 | 0.84–5.83 | 48/52 | 1.91 | 1.20–3.04 |
| 7+ | 3/5 | 1.52 | 0.27–8.59 | 13/5 | 5.90 | 1.97–17.6 |
| p-value for trend | 0.2 | <0.01 | ||||
OR, odds ratio adjusted for age, sex, residence, urban/rural status, education, family history of bladder cancer among first-degree relatives, body mass index, occupation, soft drink intake, and milk intake, and, when appropriate, maté drinking, coffee drinking, and tea drinking
CI, confidence interval.